VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 154 filers reported holding VERASTEM INC in Q4 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11 | -99.8% | 26,326 | +214.9% | 0.00% | – |
| Q3 2022 | $7,000 | -41.7% | 8,359 | -18.7% | 0.00% | – |
| Q2 2022 | $12,000 | -73.9% | 10,277 | -68.7% | 0.00% | – |
| Q1 2022 | $46,000 | -60.3% | 32,856 | -41.9% | 0.00% | -100.0% |
| Q4 2021 | $116,000 | +182.9% | 56,544 | +327.7% | 0.00% | +100.0% |
| Q3 2021 | $41,000 | -39.7% | 13,221 | -20.3% | 0.00% | -50.0% |
| Q2 2021 | $68,000 | +126.7% | 16,588 | +37.8% | 0.00% | +100.0% |
| Q1 2021 | $30,000 | -53.1% | 12,039 | -60.3% | 0.00% | -50.0% |
| Q4 2020 | $64,000 | -67.3% | 30,293 | -81.4% | 0.00% | 0.0% |
| Q3 2020 | $196,000 | -22.5% | 162,480 | +10.7% | 0.00% | -80.0% |
| Q2 2020 | $253,000 | +1586.7% | 146,839 | +2568.8% | 0.01% | +900.0% |
| Q1 2020 | $15,000 | – | 5,502 | +2956.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 180 | -99.0% | 0.00% | -100.0% |
| Q2 2019 | $27,000 | +1250.0% | 17,589 | +3040.9% | 0.00% | – |
| Q1 2019 | $2,000 | -95.1% | 560 | -90.2% | 0.00% | -100.0% |
| Q3 2018 | $41,000 | +1950.0% | 5,687 | +802.7% | 0.00% | – |
| Q1 2018 | $2,000 | -91.3% | 630 | -91.7% | 0.00% | -100.0% |
| Q4 2017 | $23,000 | +666.7% | 7,559 | +1205.5% | 0.00% | – |
| Q3 2017 | $3,000 | -72.7% | 579 | -88.5% | 0.00% | -100.0% |
| Q2 2017 | $11,000 | -42.1% | 5,027 | -45.9% | 0.00% | -50.0% |
| Q1 2017 | $19,000 | -47.2% | 9,285 | -70.8% | 0.00% | -50.0% |
| Q4 2016 | $36,000 | +2.9% | 31,788 | +21.5% | 0.00% | +33.3% |
| Q3 2016 | $35,000 | +1066.7% | 26,163 | +1468.5% | 0.00% | – |
| Q2 2016 | $3,000 | -50.0% | 1,668 | -59.4% | 0.00% | -100.0% |
| Q1 2016 | $6,000 | -60.0% | 4,107 | -49.4% | 0.00% | -50.0% |
| Q4 2015 | $15,000 | – | 8,119 | +3860.5% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 205 | -87.3% | 0.00% | -100.0% |
| Q2 2015 | $13,000 | -18.8% | 1,619 | -0.4% | 0.00% | -50.0% |
| Q1 2015 | $16,000 | -38.5% | 1,626 | -42.8% | 0.00% | -33.3% |
| Q4 2014 | $26,000 | +550.0% | 2,843 | +454.2% | 0.00% | – |
| Q3 2014 | $4,000 | +300.0% | 513 | +294.6% | 0.00% | – |
| Q1 2014 | $1,000 | -95.8% | 130 | -93.8% | 0.00% | -100.0% |
| Q4 2013 | $24,000 | -47.8% | 2,098 | -42.8% | 0.00% | -20.0% |
| Q3 2013 | $46,000 | -37.8% | 3,666 | -31.2% | 0.01% | -16.7% |
| Q2 2013 | $74,000 | – | 5,329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |